直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Webinar

Pharma and Chemical Patent Applications: Meeting Written Description Requirement

July 26, 2016

Webinar

Strafford Publications

As part of Strafford Publications’ webinar series, Finnegan attorneys Tom Irving and Amanda Murphy will present best practices to ensure that chemical and pharmaceutical patent applications meet the written description requirement. The presentation will also review lessons from Federal Circuit and PTAB decisions and will provide strategies for drafting and prosecuting pharmaceutical and chemical patent applications with an eye for future licensing opportunities, AIA post-grant proceedings, and federal district court litigation. For more information, or to register, please see Strafford’s website.

Tags

patent application

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Prosecution and Portfolio Management

Patent Drafting and Prosecution

Related Industries

Chemicals, Industrials, and Materials

Chemical

Energy

Life Sciences

Pharmaceutical

Related Professionals

Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2814
Email

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

2026 AIPLA Annual Meeting

October 29-31, 2026

Washington, DC

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

LES 2026 Annual Meeting

October 18-21, 2026

San Diego

Conference

2026 IPO Annual Meeting

September 27-29, 2026

Toronto

European IP Blog

The Decision in G 1/25: A More Relaxed Approach to Description Amendments in Europe?

3 September 2026

Lecture

Resolving Patent Suits Without Settlement Payments

September 3, 2026

Virtual

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP